Midlife Metabolic Syndrome as Mediator Between Early-Life Insulin Resistance and Later-Life Cardiovascular Diseases
JACC: Advances
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Midlife Metabolic Syndrome as Mediator Between Early-Life Insulin Resistance and Later-Life Cardiovascular Diseases. // JACC: Advances. – URL: https://www.sciencedirect.com/science/article/pii/S2772963X26008410?dgcid=rss_sd_all
Midlife Metabolic Syndrome as Mediator Between Early-Life Insulin Resistance and Later-Life Cardiovascular Diseases. JACC: Advances. https://www.sciencedirect.com/science/article/pii/S2772963X26008410?dgcid=rss_sd_all
“Midlife Metabolic Syndrome as Mediator Between Early-Life Insulin Resistance and Later-Life Cardiovascular Diseases.” JACC: Advances.
@article{article50824,
title = {Midlife Metabolic Syndrome as Mediator Between Early-Life Insulin Resistance and Later-Life Cardiovascular Diseases},
journal = {JACC: Advances},
url = {https://www.sciencedirect.com/science/article/pii/S2772963X26008410?dgcid=rss_sd_all}
}